Lehrmann E, Kiefer R, Christensen T, Toyka K V, Zimmer J, Diemer N H, Hartung H P, Finsen B
PharmaBiotec, Department of Anatomy and Cell Biology, Odense University, Denmark.
Glia. 1998 Dec;24(4):437-48. doi: 10.1002/(sici)1098-1136(199812)24:4<437::aid-glia9>3.0.co;2-x.
The potentially neurotrophic cytokine transforming growth factor-beta1 (TGF-beta1) is locally expressed following human stroke and experimental ischemic lesions, but the cellular source(s) and profile of induction have so far not been established in experimental focal cerebral ischemia. This study presents the time course and a cellular localization of TGF-beta1 mRNA, visualized by in situ hybridization combined with immunohistochemical staining for microglia, macrophages, or astrocytes, on brain sections from adult spontaneously hypertensive rats subjected to transient proximal occlusion of their middle cerebral artery. Six hours after ischemia, an early and transient neuronal and microglial expression of TGF-beta1 mRNA was observed in the extraischemic cingulate and frontal cortices. Both early and protracted expression of TGF-beta1 mRNA in the caudate-putamen and neocortical infarcts and in the caudate-putamen penumbra colocalized with OX42/ED1-immunoreactive microglia and macrophages, whereas TGF-beta1 mRNA in the neocortical penumbra colocalized with OX42/ED1-immunoreactive cells of a microglial morphology. No astrocytes were double-labeled. The number of TGF-beta1 mRNA-expressing microglia and macrophages increased strongly during the first week. Thereafter, TGF-beta1 mRNA became increasingly restricted to the neocortical penumbra (3 weeks), and after 3 months it was confined to activated microglia in the anterior commissure. Our data establish activated microglia and macrophages as the major source of TGF-beta1 mRNA following experimental focal cerebral ischemia. Consequently, TGF-beta1-mediated functions may be exerted by microglia both in the early degenerative phase, and later in combination with blood-borne macrophages, in the remodeling and healing phase after focal cerebral ischemia.
具有潜在神经营养作用的细胞因子转化生长因子-β1(TGF-β1)在人类中风和实验性缺血性损伤后会在局部表达,但在实验性局灶性脑缺血中,其细胞来源和诱导情况迄今尚未明确。本研究通过原位杂交结合对小胶质细胞、巨噬细胞或星形胶质细胞进行免疫组织化学染色,呈现了成年自发性高血压大鼠大脑中动脉短暂近端闭塞后,脑切片上TGF-β1 mRNA的时间进程和细胞定位。缺血6小时后,在缺血外的扣带回和额叶皮质观察到TGF-β1 mRNA早期短暂的神经元和小胶质细胞表达。尾状核-壳核和新皮质梗死灶以及尾状核-壳核半暗带中TGF-β1 mRNA的早期和持续性表达与OX42/ED1免疫反应性小胶质细胞和巨噬细胞共定位,而新皮质半暗带中的TGF-β1 mRNA与具有小胶质细胞形态的OX42/ED1免疫反应性细胞共定位。未发现星形胶质细胞有双重标记。在第一周内,表达TGF-β1 mRNA的小胶质细胞和巨噬细胞数量大幅增加。此后,TGF-β1 mRNA越来越局限于新皮质半暗带(3周),3个月后局限于前连合中活化的小胶质细胞。我们的数据表明,活化的小胶质细胞和巨噬细胞是实验性局灶性脑缺血后TGF-β1 mRNA的主要来源。因此,TGF-β1介导的功能可能在局灶性脑缺血后的早期退变阶段由小胶质细胞发挥,在后期重塑和愈合阶段与血源性巨噬细胞共同发挥。